Logo image
The Lazaroid U74006F, a 21-Aminosteroid Inhibitor of Lipid Peroxidation, Attenuates Myocardial Injury from Ischemia and Reperfusion
Journal article   Open access   Peer reviewed

The Lazaroid U74006F, a 21-Aminosteroid Inhibitor of Lipid Peroxidation, Attenuates Myocardial Injury from Ischemia and Reperfusion

Frank Carrea, Edward Lesnefsky, David Kaiser and Lawrence Horwitz
Journal of cardiovascular pharmacology, Vol.20(2), pp.230-235
08/1992
DOI: 10.1097/00005344-199208000-00008
PMID: 1381014
url
https://doi.org/10.1097/00005344-199208000-00008View
Published (Version of record) Open Access

Abstract

SUMMARYU74006F, a novel new 21-aminosteroid inhibitor of lipid peroxidation, has been effective in preventing free-radical-mediated injury in central nervous system models. To assess its ability to diminish myocardial injury due to ischemia and reperfusion, U74006F (n = 11) or its vehicle (n = 11) were administered intravenously to New Zealand white rabbits. After allowing for distribution, the hearts were excised and exposed to 30 min of stop-flow ischemia and 30 min of reperfusion on a nonrecirculating Langendorf apparatus. There was diminished creatine phosphokinase release; improved peak positive dP/dt, developed pressure, and peak negative dP/dt; and diminished diastolic pressure in the group treated with U74006F. Thus, pretreatment with U74006F diminished myocardial injury and enhanced systolic and diastolic functional recovery, probably by protecting the lipid component of cell membranes from peroxidation by reactive oxygen metabolites.

Details

Metrics

Logo image